FDA Inspection
Novo Nordisk A/S - G8, X9 M.FINovo Nordisk A/S - G8, X9 M.FI – FDA Inspection, Jun 16, 2022
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - G8, X9 M.FI, with an inspection on June 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 16, 2022
- Product Type
- Drugs
View Company Profile
ID · a73b5e51-19ef-492f-93ba-175b269567c1
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1297668
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novo Nordisk A/S - G8, X9 M.FI
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | Office of Inspections and Investigations | |
| May 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - G8, X9 M.FI
- FDA Inspection 1316850 - 2026-04-17
- FDA Inspection 1210000 - 2021-05-12
- FDA Inspection 1057701 - 2018-06-01
- FDA Inspection 965339 - 2016-04-14
- FDA Inspection 874067 - 2014-03-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.